-
- Ryan L. Crass
- Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA
-
- Pier Giorgio Cojutti
- Department of Medicine, University of Udine, Udine, Italy
-
- Manjunath P. Pai
- Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA
-
- Federico Pea
- Department of Medicine, University of Udine, Udine, Italy
書誌事項
- 公開日
- 2019-08
- 権利情報
-
- https://journals.asm.org/non-commercial-tdm-license
- DOI
-
- 10.1128/aac.00605-19
- 公開者
- American Society for Microbiology
この論文をさがす
説明
<jats:p>Linezolid is administered as a fixed dose to all patients despite evidence of increased exposure and myelosuppression in renal impairment. The objectives of these studies were to assess the risk of thrombocytopenia with standard-dose linezolid in renal impairment and to identify an alternate dosing strategy.</jats:p>
収録刊行物
-
- Antimicrobial Agents and Chemotherapy
-
Antimicrobial Agents and Chemotherapy 63 (8), e00605-, 2019-08
American Society for Microbiology
